Skip to main content

Remote Job Finders (RJF)

Almost 1/3 Eyeing Job Options Outside US, BioSpace Finds

Nearly one-third of biotech and pharma professionals are thinking about leaving the U.S. to find biopharma jobs, according to a BioSpace LinkedIn poll. Career coaches discuss why people are considering relocating and what they should do before heading for the exit.

FDA Formally Rejects Regeneron’s Eylea HD Over Manufacturing Issues

Despite the rejection, analysts saw Regeneron’s use of an alternate filler for Eylea HD as a positive development, with BMO Capital Markets noting that this could signal the end of manufacturing troubles for the franchise.
Scroll to top